Ask Warren

Myungin Pharm

317450 · KOSPI · ₩317450 · 명인제약

₩39,700▼ ₩300 (0.75%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
  • Amended: Cash dividend decision[기재정정]현금ㆍ현물배당결정Aug 6, 2026Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Jul 31, 2026Open on DART
  • Cash dividend decision현금ㆍ현물배당결정Jul 28, 2026Open on DART
  • Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Jul 28, 2026Open on DART
  • Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 14, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서May 8, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 8, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 8, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 8, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)May 8, 2026Open on DART
  • Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Apr 6, 2026Open on DART
  • Corporate value-up plan기업가치제고계획(자율공시)Mar 27, 2026Open on DART
  • Change of Representative Director (Representative Executive Officer) (Informational Disclosure)대표이사(대표집행임원)변경(안내공시)Mar 26, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
  • Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Mar 25, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 18, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 9, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의Feb 5, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Feb 3, 2026Open on DART
  • Cash dividend decision현금ㆍ현물배당결정Feb 3, 2026Open on DART
  • Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Dec 12, 2025Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
  • Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 12, 2025Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Oct 31, 2025Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 14, 2025Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 14, 2025Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Oct 14, 2025Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Oct 13, 2025Open on DART
  • Securities Issuance Results Report증권발행실적보고서Sep 23, 2025Open on DART
  • Amended: Prospectus[기재정정]투자설명서Sep 17, 2025Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Sep 17, 2025Open on DART
  • Prospectus투자설명서Sep 12, 2025Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Sep 3, 2025Open on DART
  • Securities registration statement증권신고서(지분증권)Aug 21, 2025Open on DART
  • Consolidated Audit Report (2024.12)연결감사보고서 (2024.12)Mar 31, 2025Open on DART
  • Audit Report (2024.12)감사보고서 (2024.12)Mar 31, 2025Open on DART
  • Consolidated Audit Report (2023.12)연결감사보고서 (2023.12)Apr 2, 2024Open on DART
  • Audit Report (2023.12)감사보고서 (2023.12)Apr 2, 2024Open on DART
  • 연결감사보고서 (2022.12)Apr 3, 2023Open on DART
  • 감사보고서 (2022.12)Apr 3, 2023Open on DART
  • 연결감사보고서 (2021.12)Apr 1, 2022Open on DART
  • 감사보고서 (2021.12)Apr 1, 2022Open on DART

Titles in Korean until English translations are added.

Also known as: Myungin Pharm / 명인제약 / 317450 / KRX:317450

Source: KRX statistical information